4-butyrolactone has been researched along with Encephalopathy, Toxic in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Feng, ZB; Li, JJ; Lu, YP; Qian, ZM; Zhao, P; Zhu, L; Zhu, Q | 1 |
| Li, J; Xu, W; Yang, L | 1 |
| Dupont, P; Thornton, J | 1 |
3 other study(ies) available for 4-butyrolactone and Encephalopathy, Toxic
| Article | Year |
|---|---|
Ligustilide prevents cognitive impairment and attenuates neurotoxicity in D-galactose induced aging mice brain.
Topics: 4-Butyrolactone; Aging; Animals; Brain; Cognition Disorders; Galactose; GAP-43 Protein; Gene Expression Regulation; Glial Fibrillary Acidic Protein; Male; Malondialdehyde; Maze Learning; Mice; Mice, Inbred ICR; Neuroprotective Agents; Neurotoxicity Syndromes; Sodium-Potassium-Exchanging ATPase; Statistics, Nonparametric | 2015 |
Protection against β-amyloid-induced neurotoxicity by naturally occurring Z-ligustilide through the concurrent regulation of p38 and PI3-K/Akt pathways.
Topics: 4-Butyrolactone; Amyloid beta-Peptides; Animals; Cell Line, Tumor; Cell Survival; Neurons; Neuroprotective Agents; Neurotoxicity Syndromes; Oncogene Protein v-akt; p38 Mitogen-Activated Protein Kinases; Peptide Fragments; Phosphatidylinositol 3-Kinases; Rats; Reactive Oxygen Species; Signal Transduction | 2016 |
Near-fatal gamma-butyrolactone intoxication--first report in the UK.
Topics: 4-Butyrolactone; Adult; Coma; Electrocardiography; GABA Modulators; Glasgow Coma Scale; Humans; Male; Neurotoxicity Syndromes | 2001 |